User:Mr. Ibrahem/Encorafenib

Encorafenib, sold under the brand name Braftovi, is a medication used to treat melanoma and colorectal cancer. Specifically it is used for cases which are BRAF V600E or V600K mutation-positive that cannot be removed by surgery. It is taken by mouth.

Common side effects include tiredness, nausea, diarrhea,, abdominal pain, rash, and joint pain. Other side effects may include bleeding, uveitis, QT prolongation, and other cancers. In those with minor liver problems a lower dose should be used. Use in pregnancy may harm the baby. It is a kinase inhibitor that blocks the BRAF protein.

Encorafenib was approved for medical use in the United States and Europe in 2018. In the United Kingdom for 4 weeks it costs the NHS about £5,600 as of 2021. In the United States this amount costs about 12,400 USD.